development capabilities, access new markets, and tap into the expertise of regional healthcare professionals. The partnership between Burjeel Holdings and BridgeBio Pharma is a prime example of this trend. By collaborating with local stakeholders in Abu Dhabi, they can leverage the advanced infrastructure and resources available in the Emirate to accelerate their research and development effort..
UAE and Saudi Arabia: Gateways to International Biopharma Markets Biopharmaceutical companies like Sanofi, AbbVie, and Virax Biolabs are capitalizing on lucrative business opportunities in the Middle East, particularly in the United Arab Emirates (UAE) and Saudi Arabia. These countries have become attractive markets for cutting-edge therapies, driven by their growing populations with a rising in..
Connect Biopharma Holdings Limited, a global clinical-stage biopharmaceutical company specializing in therapies for chronic inflammatory diseases, unveiled additional findings from its pivotal trial for atopic dermatitis during the 2023 World Congress of Dermatology. The data highlighted the effectiveness and safety of rademikibart (formerly known as CBP-201) in treating moderate-to-severe atopi..
Biopharma companies are increasingly becoming targets of ransomware attacks, with the number of breaches rising during the COVID-19 pandemic. Japanese company Eisai recently announced that it was hit by a ransomware attack, joining other pharmaceutical companies like Sun Pharmaceuticals, Novartis and AstraZeneca. According to Constella Intelligence, for the top 20 pharma companies, the total num..
